# BioPlus Acquisition Corp. (BIOS)

Source: https://www.quantisnow.com/company/BIOS
Generated: 2026-11-10T12:04:46.471Z

- Ticker: BIOS
- Exchange: NASDAQ
- Sector: Finance
- Industry: Blank Checks
- IPO year: 2022
- Website: https://bioplusspac.com

## About

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

## Latest BIOS news and filings

- 2026-01-07 13:00 UTC [Public Offering] [ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors](https://www.quantisnow.com/insight/realta-life-sciences-announces-appointment-of-jonathan-rigby-to-board-6340318)
- 2024-02-12 21:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bioplus-acquisition-corp-amendment-5250286)
- 2024-02-09 15:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bioplus-acquisition-corp-amendment-5245165)
- 2024-02-07 19:00 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bioplus-acquisition-corp-amendment-5237045)
- 2024-01-19 20:46 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bioplus-acquisition-corp-amendment-5196250)
- 2023-10-16 20:15 UTC [SEC Form 15-12G filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-bioplus-acquisition-corp-5022016)
- 2023-10-06 20:03 UTC [SEC Form 25-NSE filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-bioplus-acquisition-corp-5009311)
- 2023-10-04 11:39 UTC [SEC Form RW filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-bioplus-acquisition-corp-5003166)
- 2023-10-04 11:38 UTC [Market Chatter] [Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination](https://www.quantisnow.com/insight/avertix-and-bios-acquisition-corporation-mutually-agree-to-terminate-proposed-5003161)
- 2023-10-04 11:32 UTC [SEC Form 8-K] [BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bioplus-acquisition-corp-filed-sec-form-8-k-entry-into-a-5003141)
- 2023-10-04 11:30 UTC [Public Offering] [BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate](https://www.quantisnow.com/insight/bioplus-acquisition-corp-announces-termination-of-business-combination-agreement-with-5003117)
- 2023-10-04 11:30 UTC [Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination](https://www.quantisnow.com/insight/avertix-and-bios-acquisition-corporation-mutually-agree-to-terminate-proposed-5003109)
- 2023-09-15 20:00 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4973387)
- 2023-08-29 07:03 UTC [Carbonhand is available for Veterans in the US](https://www.quantisnow.com/insight/carbonhand-is-available-for-veterans-in-the-us-4941627)
- 2023-08-16 13:01 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4905062)
- 2023-08-16 12:32 UTC [Market Chatter] [Heart & Rhythm Institute Of Trinity And Avertix Announce Partnership To Improve Cardiac Care And Patient Monitoring](https://www.quantisnow.com/insight/heart-rhythm-institute-of-trinity-and-avertix-announce-partnership-to-4904714)
- 2023-08-16 12:30 UTC [Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring](https://www.quantisnow.com/insight/heart-rhythm-institute-of-trinity-and-avertix-announce-partnership-to-4904684)
- 2023-08-16 07:12 UTC [Carbonhand available in the US through Veterans Healthcare Supply Solutions](https://www.quantisnow.com/insight/carbonhand-available-in-the-us-through-veterans-healthcare-supply-solutions-4903618)
- 2023-08-14 20:11 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bioplus-acquisition-corp-4894244)
- 2023-08-01 20:53 UTC [SEC Form S-4] [SEC Form S-4/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-bioplus-acquisition-corp-amendment-4828926)
- 2023-07-17 12:01 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4758707)
- 2023-07-17 12:00 UTC [Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical's Board of Directors](https://www.quantisnow.com/insight/renown-cardiologist-and-professor-ian-t-meredith-md-to-join-4758629)
- 2023-06-29 23:42 UTC [SEC Form S-4] [SEC Form S-4/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-bioplus-acquisition-corp-amendment-4706527)
- 2023-06-14 10:08 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4638619)
- 2023-06-14 10:05 UTC [SEC Form 8-K] [BioPlus Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bioplus-acquisition-corp-filed-sec-form-8-k-regulation-fd-disclosure-4638610)
- 2023-06-13 12:30 UTC [Avertix's Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando](https://www.quantisnow.com/insight/avertixs-guardian-system-first-and-only-fda-approved-implantable-heart-attack-4633941)
- 2023-06-13 01:44 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by BioPlus Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-bioplus-acquisition-corp-amendment-4632949)
- 2023-06-13 01:17 UTC [SEC Form 4] [SEC Form 4 filed by Bioplus Sponsor Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-bioplus-sponsor-llc-4632502)
- 2023-06-08 20:17 UTC [SEC Form 8-K] [BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bioplus-acquisition-corp-filed-sec-form-8-k-entry-into-a-4621117)
- 2023-05-30 20:03 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4576831)
- 2023-05-30 20:01 UTC [SEC Form 8-K] [BioPlus Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bioplus-acquisition-corp-filed-sec-form-8-k-regulation-fd-disclosure-4576809)
- 2023-05-19 20:49 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4534378)
- 2023-05-19 20:04 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4533423)
- 2023-05-15 20:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-bioplus-acquisition-corp-4506648)
- 2023-05-12 20:15 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-bioplus-acquisition-corp-4496849)
- 2023-05-03 12:49 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4434391)
- 2023-05-03 12:46 UTC [SEC Form 425] [SEC Form 425 filed by BioPlus Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-425-filed-by-bioplus-acquisition-corp-4434368)
- 2023-05-03 12:43 UTC [SEC Form 8-K] [BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bioplus-acquisition-corp-filed-sec-form-8-k-entry-into-a-4434341)
- 2023-05-03 12:41 UTC [Market Chatter] [Avertix, Maker Of Only FDA-Approved Implantable Heart Attack Warning System, To Become Publicly Traded Via Merger With BIOS Acquisition Corporation](https://www.quantisnow.com/insight/avertix-maker-of-only-fda-approved-implantable-heart-attack-warning-system-4434315)
- 2023-05-03 12:30 UTC [Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation](https://www.quantisnow.com/insight/avertix-maker-of-first-and-only-fda-approved-implantable-heart-attack-4434140)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIOS
- Earnings history: https://www.quantisnow.com/earnings/BIOS
- Dividend history: https://www.quantisnow.com/dividends/BIOS
- Insider transactions: https://www.quantisnow.com/insiders/BIOS
- Options chain: https://www.quantisnow.com/options/BIOS
- SEC 8-K filings only: https://www.quantisnow.com/company/BIOS/8-k
- RSS and alerts for BIOS: https://www.quantisnow.com/docs/rss-feeds.md